People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intelomed, Inc. | — | Biotechnology | Seed | $13.4M | $22.3M | 2013 |
MaryDel Brady at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MaryDel Brady on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mary Del Brady | 1 | 4 |
| James Sweeney | 1 | 3 |
| William P. Malloy | 1 | 3 |
| John Moran | 1 | 2 |
| R STEPHEN DOYLE | 1 | 2 |
| Frank J. Amoruso | 1 | 2 |
| Jan Berkow | 1 | 1 |
| Mark P. Rossi | 1 | 1 |
| Michael Stephen Dignazio | 1 | 1 |
| Jill F. Schiaparelli | 1 | 1 |
| Ned Laubacher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.